Saltzman, A <br/><br/>
Transforming growth factor-beta-mediated apoptosis in the Ramos B-lymphoma cell line is accompanied by caspase activation and Bcl-XL downregulation.  [electronic resource] 

 -  Experimental cell research  Jul 1998 
 - 244-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0014-4827 
<br/><br/><label>Standard No.: </label>10.1006/excr.1998.4096  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Chloromethyl Ketones--pharmacology<br/>Annexin A5--metabolism<br/>Apoptosis--physiology<br/>Apoptosis Regulatory Proteins<br/>B-Lymphocytes--cytology<br/>Burkitt Lymphoma<br/>Caspase 3<br/>Caspases<br/>Cell Cycle<br/>Cysteine Endopeptidases--metabolism<br/>Cysteine Proteinase Inhibitors--pharmacology<br/>DNA--analysis<br/>Enzyme Activation<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>I-kappa B Proteins<br/>Membrane Proteins<br/>Mitochondrial Proteins<br/>Proteins--genetics<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins c-bcl-2--analysis<br/>RNA, Messenger--analysis<br/>Transforming Growth Factor beta--pharmacology<br/>Tumor Cells, Cultured<br/>X-Linked Inhibitor of Apoptosis Protein<br/>bcl-X Protein<br/>fas Receptor--genetics